BioSpace News Archive

Business

Bay Area’s Outset Medical Names a COO and Commercial Strategy VP

The two new execs bring global operations and commercialization expertise to the company.

November 20, 2017
·
4 min read
Boehringer Ingelheim Makes Many of Its Best Molecules Openly Available to the Scientific Community Via opnMe.com to Unlock Their Full Potential

The platform offers direct access to molecules for independent research as well as other molecules for partnering with Boehringer Ingelheim.

November 20, 2017
·
3 min read
Business

Eleven Biotherapeutics Reports Third Quarter 2017 Financial Results

Cash and cash equivalents were $11.3 million as of September 30, 2017, compared to $25.3 million as of December 31, 2016.

November 20, 2017
·
11 min read
Lone Star Bio

ASPiRA Labs Announces Release of Final CMS Reimbursement Rate for OVA1

ASPiRA LABS and the exclusive distributor of OVA1, and Overa, today announced that the CMS has released the Final 2018 Clinical Lab Fee Schedule, effective January 1, 2018.

November 20, 2017
·
5 min read
Genetown

Check-Cap Announces $2.5M Registered Direct Offering

Check-Cap today announced that it has entered into definitive agreements with institutional investors for the purchase of 2,272,640 ordinary shares, at a purchase price of $1.10 per share.

November 20, 2017
·
4 min read
Policy

Orexo’s Zubsolv Receives Authorization for Treatment of Opioid Dependence in Europe

Orexo today announce that the EMA has granted a MA for Zubsolv (buprenorphine and naloxone).

November 20, 2017
·
3 min read
Drug Development

ATCC Develops Novel in Vitro Model to Investigate Drug Candidates for Cancer Metastasis

This model is part of a larger effort by ATCC researchers to develop a portfolio of clinically relevant models and biomaterials for therapeutic discovery and development.

November 20, 2017
·
2 min read
Lone Star Bio

Houston-Area Resident Carrie Rand Reestablishes Her Running Career After Total Knee Replacement Surgery

Unique knee implant allowed her to lose nearly 70 pounds and get back into running shape.

November 20, 2017
·
3 min read
Zealand Increases Its Share Capital as a Consequence of Exercise of Employee Warrants - Nov. 20, 2017

The exercise price was DKK 87.45 per share and the total proceeds to Zealand from the capital increase amount to DKK 218,625.00.

November 20, 2017
·
2 min read
Genetown

Flexion Therapeutics Announces Full Commercial Launch and Nationwide Availability of ZILRETTA (Triamcinolone Acetonide Extended-Release Injectable Suspension)

Flexion has hired and trained more than 100 field sales representatives, known as Musculoskeletal Business Managers, who are now deployed across the country.

November 20, 2017
·
6 min read